Navigation Links
Runners Take to the Streets in Undies to Fight Colon Cancer
Date:10/21/2011

DALLAS, Oct. 21, 2011 /PRNewswire/ -- The Undy 5000 5K Run/Walk to fight colon cancer is returning to Dallas for the fourth consecutive year. This year's event will take place on Saturday, October 29 at 8:30 a.m. at Winfrey Point at White Rock Lake. The Colon Cancer Alliance (CCA), a national patient advocacy organization, will host the event to help bring greater awareness to colon cancer, the second leading cause of cancer death in the United States.

"Last year, we had more than 650 people participate in the Dallas Undy 5000, including 14 fantastic colon cancer survivors," said Todd Setter, national Undy 5000 event director. "We hope this year to have twice as many participants and survivors – that's what this event is all about, after all – early detection and surviving!"

To kick off the race and celebrate the creativity and dedication of participants, the CCA is proud to launch the first-ever "Parade of Undies" fashion show in Dallas, sponsored by the makers of Dulcolax® products. Unlike other 5K races, the Undy 5000 is unique. Rather than wear race day t-shirts, participants wear specially designed boxer-style shorts, providing a fun way to bring attention to a serious disease. Additionally, Miss Texas Vivian Ta, originally crowned Miss Dallas United America 2011, will serve as host for the Dallas "Parade of Undies" fashion show. Vivian's platform is Early Detection of Colon Cancer in honor of her father who is a rectal cancer survivor.

The Undy 5000 – a family-oriented event open to all ages – is held in cities nationwide to educate the public about colon cancer, promote screenings and encourage people to talk about the disease. The event raises much needed funds to support and build the CCA's national and local patient support and public awareness programs. In addition, a portion of the funds raised from the Dallas Undy 5000 will be distributed locally to fund services for those diagnosed with colon cancer. In addition to the 5K, there will be a 1-mile family fun run.

The Undy 5000, created by the CCA, stresses the importance of timely colon cancer screening and also provides valuable information for those already affected by the disease. The CCA and Dulcolax are very excited to have local CVS pharmacy stores partnering to raise awareness of colon cancer. Undy 5000 sign-up information can be found in local Dallas CVS stores.

The makers of Dulcolax®* are the proud presenting sponsor of the 2011 Undy 5000 races. A portion of the proceeds from Dulcolax product purchases supports Colon Cancer Alliance community screening programs. As the #1 doctor recommended laxative brand**, Dulcolax reminds everyone over the age of 50 or with a family history of colon cancer, that a colonoscopy can save lives.

"We love coming to Dallas," said Andrew Spiegel, Chief Executive Officer of the Colon Cancer Alliance.  "This is our fourth race here, and I fully expect this year's Dallas Undy to shatter participation and fundraising records!"

More information about the Undy 5000 is available online at www.undy5000.org.

Created by the CCA in 2008, the Undy 5000 stresses the importance of timely colon cancer screenings, early detection, and provides valuable information for those already affected by the disease. Event proceeds help fund the CCA's patient support and public awareness programs. Part of the proceeds will also be left behind to help fund colon cancer support services at Mary Crowley Cancer Research Center.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies. The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.

The Colon Cancer Alliance (CCA) is a national patient advocacy organization dedicated to ending the suffering caused by colorectal cancer. In order to increase screening and survivorship rates, the CCA provides education and patient support, furthers research efforts, and conducts advocacy work across the country.

*Dulcolax® products are marketed and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.

**Among stimulant laxatives


'/>"/>
SOURCE Boehringer Ingelheim Pharmaceuticals, Inc. and Colon Cancer Alliance
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. While Ethicon Endo-Surgery and Allergan Remain Front-Runners in the $41 Million Gastric Band Market, Other Competitors Battle for Third Place, According to Millennium Research Group
2. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
3. Duane Reade and Smith Electric Vehicles Partner to Bring All-Electric Delivery Vehicles to New Yorks Streets
4. Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day on October 1
5. Antibiotics Conference Addresses Lack of New Drugs to Fight Deadly Superbugs
6. ChromaDex®s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers
7. Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution
8. NADDI and the C.A.R.E.S. Alliance Join Attorney General Bondi in Fight Against Prescription Drug Abuse
9. Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes
10. Scientists Use Live Bacteria to Fight HIV
11. Leaders in Fight Against Cancer Join Historic Initiative to Address Critical Shortage of Clinical Investigators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/12/2017)... June 12, 2017 Kineta, Inc., a biotechnology company ... Kineta Vice President of R&D and Head of Virology ... Pandemic Preparedness for the Northwest and Beyond meeting sponsored ... June 14, 2017 from 8:30-10:30 AM PDT at the Agora ... Dr. Bedard will be joined by other leaders ...
(Date:6/8/2017)... Fla. , June 8, 2017  Less than ... that hit more than 200,000 companies, including hospital networks, ... being heralded as one of the largest online extortion ... in the healthcare market, it is imperative that providers ... protect their data from this — and many other ...
(Date:6/7/2017)... June 6, 2017  Diplomat Specialty Infusion Group, a brand of ... to its Iowa location. The ... now features an ISO 7 cleanroom—the standard needed to compound ... a low level of pollutants. ... consumers and better serve our Iowa patients," ...
Breaking Medicine Technology:
(Date:6/20/2017)... DIEGO, California (PRWEB) , ... June 20, 2017 ... ... product documentation and help content solutions for the enterprise, is proud to announce ... properties, including CRM, e-commerce, ticketing systems, company websites, and more to provide a ...
(Date:6/20/2017)... Cincinnati, Ohio (PRWEB) , ... June 20, 2017 ... ... with gum disease in Cincinnati, OH for leading-edge care, whether or ... advances in laser dentistry. Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria ...
(Date:6/20/2017)... ... June 20, 2017 , ... With certifications and experience ... in Denville, NJ, Drs. Adam and Hal Kimowitz are currently accepting new patients at ... traditional orthodontics can cause for some patients, which is why they offer the latest ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants ... focused on finding product improvements that could reduce the occurrence of unplanned extubations ... need help breathing or to provide medication. Sometimes, patient movement can cause unplanned ...
(Date:6/20/2017)... , ... June 20, 2017 , ... ... makers of SweetLeaf® Stevia Sweetener, Michael P. May, Ph.D., recently accepted the distinguished ... Export Recognition Program selected Wisdom Natural Brands (WNB), and 16 other businesses from ...
Breaking Medicine News(10 mins):